Practice Guide – Motor Neurone Disease
DISCLOSURE LOG DOCUMENT 3 FOI 23/24 - 0845
Page 58 of 220
FOI 23/24 - 0845
Contents
-
- Purpose ………………………………………………………………………………………………………. 3
-
- To be used by ………………………………………………………………………………………………. 3
-
- Scope ………………………………………………………………………………………………………….. 3
- 3.1 Motor Neurone Disease (MND) ……………………………………………………………………. 3
- 3.2 Functional impacts of MND ………………………………………………………………………….. 3
-
- Pre-planning ………………………………………………………………………………………………… 4
- 4.1 Primary disability ……………………………………………………………………………………….. 4
- 4.2 Severity indicator tool …………………………………………………………………………………. 4
- 4.3 Streaming …………………………………………………………………………………………………. 4
- 4.4 Plan duration …………………………………………………………………………………………….. 4
- 4.5 Making appointments………………………………………………………………………………….. 5
- 4.6 Planning conversations ……………………………………………………………………………….. 5
-
- Planning ………………………………………………………………………………………………………. 6
- 5.1 Documenting comments in a participant’s plan ………………………………………………. 6
- 5.2 Core supports ……………………………………………………………………………………………. 7
- 5.3 Capacity Building supports ………………………………………………………………………….. 8
- 5.4 Capital supports …………………………………………………………………………………………. 9
-
- Supporting material ……………………………………………………………………………………… 11
-
- Feedback …………………………………………………………………………………………………… 11
-
- Version change control ………………………………………………………………………………… 12
V11.0 2021-01-12 Practice Guide – Motor Neurone Disease Page 2 of 12 This document isPageuncontrolled59 of 220 when printed.
Purpose
The purpose of this Practice Guide is to support National Disability Insurance Agency (NDIA) planners and delegates when planning with participants living with Motor Neurone Disease (MND) to understand their disability, support needs and create a positive experience as they engage and connect with the National Disability Insurance Scheme (NDIS).
To be used by
- Plan Developers – Planners
- NDIA Plan Delegates
- Business Support Officers
redacted: s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12 Practice Guide – Motor Neurone Disease Page 3 of 12 This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
redacted: s22(1)(a)(ii) - irrelevant
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 4 of 12
This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 5 of 12
This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 6 of 12
This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 7 of 12
This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 8 of 12
This document is uncontrolled when printed.
5.3.2 Support Coordination
Participants living with MND are streamed Super Intensive due to the frequent support equired in progressing through the NDIS Pathway. Make sure there is sufficient funding for coordination of supports in Capacity Building > Support Coordination.
Part of the support coordinator’s role is to assist the participant with resolving points of concern, unexpected service delivery issues, developing capacity and resilience in a participant’s network, and coordinating supports from a range of suppliers or providers.
This role includes providing the NDIS with any assessments and reports completed during the plan period. Support coordination reports and/or updates based on their experience planning with the participant must also be provided.
As with all services, the participant retains choice and control as to their preferred provider for s \support coordination.
Refer to the Standard Operating Procedure – Include Support Coordination in a Plan for further information.
redacted: s22(1)(a)(ii) - irrelevant
V11.0 2021-01-12 Practice Guide – Motor Neurone Disease Page 9 of 12 This document is uncontrolled when printed.
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
Practice Guide – Motor Neurone Disease
Page 10 of 12
This document is uncontrolled when printed.
Practice Guide – Motor Neurone Disease
redacted: s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
This document is uncontrolled when printed.
Page 11 of 12
Practice Guide – Motor Neurone Disease
FOI 23/24 - 0845
s22(1)(a)(ii) - irrelevant material
V11.0 2021-01-12
This document is uncontrolled when printed.
Page 12 of 12